Nanotechnology-Based Materials for Drug Targeting, Drug Delivery and Cell Therapy
A special issue of Journal of Functional Biomaterials (ISSN 2079-4983). This special issue belongs to the section "Biomaterials for Drug Delivery".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 1054
Special Issue Editor
Interests: nanomedicine; nanotechnology; tissue engineering; drug delivery; nanofibers; shape memory tissue
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Nanotechnology and the successful development of new nanomaterials provide new ideas and potential methods for promoting drug targeting, drug delivery, and cell therapy. Nanomaterials have unique physicochemical and biological properties that can effectively enhance the therapeutic efficacy by improving the pharmacokinetic and pharmacodynamic properties of encapsulated drugs, including drug stability, and achieving targeted drug delivery and controlled drug release due to their special characteristics of size, shape, charge and functionalizations. Until now, smart nanomaterials have been engineered with endogenous stimulators such as pH, reactive oxygen species, glutathione, hypoxia and enzyme, or exogenous stimulators such as temperature, light, ultrasound, radiation, and magnetic field. These stimuli-responsive nanomaterials find application in drug delivery, diagnostics, theranostics, tumor imaging, cancer therapy, and biomedical devices. Furthermore, nanomaterials with superior physiochemical properties have been developed and integrated into cell engineering and therapy for translating their great promise into clinical success. Nanomaterials are increasingly playing a key role in cell engineering and therapy such as cell isolation from a heterogeneous cell population, in vitro cell education to enable desired functionalities, MSCs differentiation and targeted delivery of cells to therapeutic sites to stimulate tissue regeneration.
Researchers are welcome to submit reviews and original research papers focusing on nanotechnology for drug targeting, drug delivery and controlled drug release, as well as cell therapy.
Dr. Silvia Pisani
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Functional Biomaterials is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanotechnology
- nanomaterials
- biomaterials
- drug targeting
- drug delivery
- cell therapy
- stimuli-responsive nanomaterials
- nanomedicine
